Literature DB >> 8090799

Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics.

C E Lau1, J L Falk.   

Abstract

Locomotor activity increase was a bitonic function of acute caffeine IP doses (2.5-40 mg/kg) in rats. When the schedule-induced polydipsic, orally self-administered dose of caffeine was increased over blocks of daily 3 h sessions from 9.3 to 36.5 mg/kg, postsession activity increased monotonically as a function of dose. The rate of tolerance development to the increase in locomotor activity produced by caffeine depended on the route of administration. Tolerance onset occurred on the fourth day of chronic IP doses, but remained incomplete after 21 doses. With the highest dose level of oral caffeine self-administration, tolerance developed on day 13, but remained incomplete even after 17 doses. Acute tolerance occurred for each of the IP doses, whereas a linear relation between locomotor activity and serum caffeine concentration was obtained after oral self-administration. There were two- to threefold higher locomotor activity AUCs(4 h) with oral caffeine at three dose levels compared to the activity AUCs(4 h) for IP doses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090799     DOI: 10.1016/0091-3057(94)90535-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

2.  Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components.

Authors:  Hiroaki Takemoto; Michiho Ito; Tomohiro Shiraki; Toru Yagura; Gisho Honda
Journal:  J Nat Med       Date:  2007-08-23       Impact factor: 2.343

3.  Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.

Authors:  Jessica Ruiz-Medina; Ana Pinto-Xavier; Marta Rodríguez-Arias; José Miñarro; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

Review 4.  Adenosine receptor ligands: differences with acute versus chronic treatment.

Authors:  K A Jacobson; D K von Lubitz; J W Daly; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1996-03       Impact factor: 14.819

Review 5.  Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine.

Authors:  Sergi Ferré
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.160

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.